Ropinirole oral spray - NovaDel Pharma

Drug Profile

Ropinirole oral spray - NovaDel Pharma

Alternative Names: NVD-434

Latest Information Update: 11 Apr 2011

Price : $50

At a glance

  • Originator NovaDel Pharma
  • Class Amines; Antiparkinsonians; Indoles; Sleep disorder therapies; Small molecules
  • Mechanism of Action Dopamine D2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Parkinson's disease

Most Recent Events

  • 31 Dec 2007 Phase-I clinical trials in Parkinson's disease in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top